Imaging Approaches in Prostate Cancer
Daniel P. Petrylak, MD, director, Prostate and GU Medical Oncology, Yale Cancer Center, describes imaging approaches in prostate cancer.
Clinical Pearls I
Daniel P. Petrylak, MD, director, Prostate and GU Medical Oncology, Yale Cancer Center, describes imaging approaches in prostate cancer.
- Sodium fluoride PET represents a sensitive way of detecting bone metastases
- Sodium fluoride PET is reasonable to use before treatment with enzalutamide, sipuleucel-T, or abiraterone, in patients with rising PSA and negative conventional imaging
Clinical Pearls II
- The Artemis device is being looked at in clinical studies to help detect prostate cancer in localized biopsies
- Sodium acetate PET and amino acid imaging are still under investigation
- Petrylak is interested in research into imaging for targeted therapies to check for activity and eligibility
Recent Videos
Related Content
